Study #2020-0746
Blood based biomarkers for minimal residual disease detection in pediatric sarcomas.
MD Anderson Study Status
Enrolling
Treatment Agent
Description
Biomarkers for minimal residual disease detection in pediatric sarcomas
Resources and Links
Phone Number: 1-877-MDA-6789
clinicaltrials.gov NCT No: N/A
Information and next steps
Disease:
Study phase:
Not applicable
Physician name:
Jonathan Gill
Department:
Pediatrics
For general questions about clinical trials:
1-866-967-2182
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.